Stratos Wealth Partners LTD. Has $741,000 Holdings in HCA Healthcare, Inc. $HCA

Stratos Wealth Partners LTD. trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,934 shares of the company’s stock after selling 42 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in HCA Healthcare were worth $741,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter worth $1,021,000. GAMMA Investing LLC boosted its position in HCA Healthcare by 17.6% during the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after acquiring an additional 737 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in shares of HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock valued at $1,491,000 after purchasing an additional 105 shares during the period. Oppenheimer & Co. Inc. grew its position in HCA Healthcare by 0.9% during the first quarter. Oppenheimer & Co. Inc. now owns 13,390 shares of the company’s stock valued at $4,627,000 after purchasing an additional 121 shares in the last quarter. Finally, Asset Management One Co. Ltd. lifted its position in HCA Healthcare by 1.4% in the 1st quarter. Asset Management One Co. Ltd. now owns 76,561 shares of the company’s stock worth $26,456,000 after buying an additional 1,035 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 2.1%

Shares of HCA Healthcare stock opened at $441.08 on Thursday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $443.41. The company’s fifty day simple moving average is $412.90 and its 200-day simple moving average is $380.12. The company has a market cap of $103.21 billion, a price-to-earnings ratio of 18.54, a PEG ratio of 1.37 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm’s revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is 12.11%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HCA. Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a report on Thursday, August 14th. JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Barclays increased their price target on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research note on Thursday, September 18th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $444.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $437.19.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.